Published in Genes Chromosomes Cancer on November 01, 1995
Genetic progression and divergence in pancreatic carcinoma. Am J Pathol (2000) 1.53
The CDKN2A (p16) gene and human cancer. Mol Med (1997) 1.46
Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (1997) 1.29
Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol (2000) 1.28
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing. PLoS One (2012) 1.21
p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb. Ann Surg (2002) 1.17
Genetic alterations in pancreatic cancer. World J Gastroenterol (2007) 0.89
Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration. Gastroenterol Res Pract (2012) 0.89
Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia. J Oncol (2015) 0.84
Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. Pancreas (2015) 0.80
Cytogenetic and FISH analyses of pancreatic carcinoma reveal breaks in 18q11 with consistent loss of 18q12-qter and frequent gain of 18p. Br J Cancer (1998) 0.77
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet (1993) 4.38
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene (2007) 2.83
Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature (1987) 2.54
The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet (2001) 2.46
Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med (1995) 2.34
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A (1994) 2.25
Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst (2001) 2.10
Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg (1996) 2.06
A pseudoautosomal gene in man. Science (1986) 1.94
Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature (2000) 1.84
Transplantation of the parathyroid glands in man: clinical indications and results. Surgery (1975) 1.84
Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet (1994) 1.79
Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet (1995) 1.66
Tumors of the small intestine. Semin Oncol (1988) 1.66
MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet (1999) 1.61
Rapid cloning and characterization of new chromosome 10 DNA markers by Alu element-mediated PCR. Genomics (1990) 1.59
A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid. J Clin Endocrinol Metab (1974) 1.52
Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg (1996) 1.51
Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg (1980) 1.51
Evolutionary conservation of the human homologue of the yeast cell cycle control gene cdc2 and assignment of Cd2 to chromosome 10. Hum Genet (1988) 1.47
Parathyroid adenomas in the aortopulmonary window. Radiology (1996) 1.46
Parathyroid transplantation. World J Surg (1977) 1.45
Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res (1992) 1.43
The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II. Ann Surg (1975) 1.43
Lethality of multiple endocrine neoplasia type I. World J Surg (1998) 1.35
Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res (1995) 1.35
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol (1998) 1.33
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma. Ann Surg (1978) 1.33
Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg (1993) 1.32
Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ (1992) 1.29
A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N Engl J Med (1981) 1.26
Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients. Ann Surg (1977) 1.25
The transplanted parathyroid gland: evaluation of cryopreservation and other environmental factors which affect its function. Surgery (1974) 1.25
Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg (1978) 1.25
Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg (1978) 1.25
Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med (1976) 1.25
Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg (1986) 1.24
Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am (1979) 1.22
Transplantation of the parathyroid glands: current status. Surg Clin North Am (1979) 1.22
Pseudogout after parathyroidectomy. Lancet (1973) 1.19
Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17
The pseudoautosomal boundary in man is defined by an Alu repeat sequence inserted on the Y chromosome. Nature (1989) 1.17
Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery (1993) 1.16
Transplantation of the parathyroid glands in dogs. Biochemical, histological, and radioimmunoassay proof of function. Transplantation (1973) 1.16
Surgical treatment of primary hyperaldosteronism. Ann Surg (1994) 1.16
Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J Natl Cancer Inst (1979) 1.15
Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma--an effect apparently not mediated by gastrin. Metabolism (1975) 1.15
Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res (1993) 1.13
Strong linkage disequilibrium between the XY274 polymorphism and the pseudoautosomal boundary. Am J Hum Genet (1990) 1.13
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. Cancer (1977) 1.12
Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg (1996) 1.11
Familial medullary carcinoma of the thyroid, adrenal pheochromocytoma and parathyroid hyperplasia. A syndrome of multiple endocrine neoplasia. Radiology (1973) 1.10
Inherited medullary thyroid carcinoma: a final monoclonal mutation in one of multiple clones of susceptible cells. Science (1978) 1.10
Parathyroid localization by angiographic techniques in patients with previous neck surgery. Br J Radiol (1973) 1.09
Preoperative localization of abnormal parathyroid tissue. Cumulative experience with venous sampling and arteriography. Am J Med (1973) 1.09
Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers. Cancer Res (1991) 1.08
Mapping the limits of the human pseudoautosomal region and a candidate sequence for the male-determining gene. Nature (1987) 1.08
Clinical significance of microsatellite instability in endometrial carcinoma. Cancer (2000) 1.07
Use of aminoglutethimide and hydrocortisone as a "medical adrenalectomy" for treatment of breast carcinoma. Prog Clin Cancer (1982) 1.07
A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinog (1999) 1.07
Primary hyperparathyroidism. Curr Probl Surg (1980) 1.06
Reoperation for recurrent or persistent medullary thyroid cancer. Surgery (1993) 1.06
Foetal antigens cross-reactive with tumour-specific transplantation antigens. Nat New Biol (1973) 1.05
Parathyroid autotransplantation. Surgery (1993) 1.05
K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann Surg (1998) 1.05
Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer (1997) 1.04
Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology (1997) 1.02
Morphological and biochemical properties of a new human breast cancer cell line. Cancer Res (1979) 1.02
Advances in the diagnosis and treatment of medullary thyroid carcinoma. Surg Clin North Am (1987) 1.02
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab (1982) 1.01
Osteomalacia after parathyroidectomy in patients with uremia. Ann Intern Med (1982) 1.01
Phylogenetic conservation and physical mapping of members of the H6 homeobox gene family. Mamm Genome (1995) 1.01
Colon ulceration and perforation in cyclic neutropenia. J Pediatr Surg (1973) 0.99
Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. Hum Mol Genet (1995) 0.98
Transplantation of the parathyroid glands in man. Transplant Proc (1977) 0.98
Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2----q26.3. Hum Genet (1991) 0.98
A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locus. Proc Natl Acad Sci U S A (1993) 0.98
Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Cancer (1978) 0.98
Localization and linkage of three polymorphic DNA sequences on human chromosome 20. Cytogenet Cell Genet (1987) 0.98
Surgical management of patients with persistent or recurrent medullary thyroid cancer. J Intern Med (1998) 0.98
A cluster of CpG islands at D10S94, near the locus responsible for multiple endocrine neoplasia type 2A (MEN2A). Genomics (1992) 0.97
Comparison of the mechanisms underlying carbohydrate intolerance in subclinical diabetic women during pregnancy and during post-partum oral contraceptive steroid treatment. J Clin Endocrinol Metab (1969) 0.97
Review of GCDFP-15. An apocrine marker protein. Ann N Y Acad Sci (1990) 0.97
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study. Ann Oncol (2009) 0.96
Genetic analysis of kifafa, a complex familial seizure disorder. Am J Hum Genet (1995) 0.95
Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma. J Clin Invest (1980) 0.95
In vitro neoplastic transformation of newborn hamster salivary-gland tissue by oncogenic DNA viruses. Cancer (1966) 0.95
Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics (1991) 0.95
Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg (1983) 0.95
PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol (1998) 0.95
The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast. Cancer (1980) 0.94
Repeated neck exploration in primary hyperparathyroidism: localization of abnormal glands by selective thyroid arteriography, selective venous sampling, and radioimmunoassay. Surgery (1973) 0.93
Antibody reacting with mouse mammary tumor virus in serum of breast carcinoma patients. Surg Forum (1976) 0.93